Anna Germanová

484 total citations
18 papers, 316 citations indexed

About

Anna Germanová is a scholar working on Obstetrics and Gynecology, Epidemiology and Oncology. According to data from OpenAlex, Anna Germanová has authored 18 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Obstetrics and Gynecology, 8 papers in Epidemiology and 5 papers in Oncology. Recurrent topics in Anna Germanová's work include Endometrial and Cervical Cancer Treatments (7 papers), Advanced Glycation End Products research (5 papers) and Ovarian cancer diagnosis and treatment (5 papers). Anna Germanová is often cited by papers focused on Endometrial and Cervical Cancer Treatments (7 papers), Advanced Glycation End Products research (5 papers) and Ovarian cancer diagnosis and treatment (5 papers). Anna Germanová collaborates with scholars based in Czechia, United Kingdom and United States. Anna Germanová's co-authors include Tomáš Zima, Marta Kalousová, Z Hájek, Antonı́n Pařı́zek, Michal Koucký, David Cibula, J Sláma, Roman Kocián, Ladislav Dušek and D. Fischerová and has published in prestigious journals such as British Journal of Cancer, Annals of Surgical Oncology and Gynecologic Oncology.

In The Last Decade

Anna Germanová

18 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Germanová Czechia 11 207 111 100 66 48 18 316
Rafli van de Laar Netherlands 10 96 0.5× 65 0.6× 133 1.3× 72 1.1× 13 0.3× 16 274
Juria Akasaka Japan 9 201 1.0× 16 0.1× 143 1.4× 21 0.3× 77 1.6× 23 307
Tatjana E. Vogelvang Netherlands 12 123 0.6× 140 1.3× 21 0.2× 82 1.2× 13 0.3× 21 435
Liv Cecilie Vestrheim Thomsen Norway 12 305 1.5× 61 0.5× 18 0.2× 54 0.8× 108 2.3× 33 439
Nadiye Köroğlu Türkiye 10 127 0.6× 31 0.3× 74 0.7× 102 1.5× 23 0.5× 56 301
Nikolaos Burbos United Kingdom 11 194 0.9× 28 0.3× 129 1.3× 12 0.2× 12 0.3× 30 297
Xiuli Yang China 9 91 0.4× 43 0.4× 139 1.4× 47 0.7× 85 1.8× 28 276
Thomas Gaillard France 8 62 0.3× 38 0.3× 46 0.5× 10 0.2× 9 0.2× 40 196
Ahter Tanay Tayyar Türkiye 11 163 0.8× 19 0.2× 65 0.7× 101 1.5× 39 0.8× 40 327
Panos Sarhanis United Kingdom 10 134 0.6× 103 0.9× 81 0.8× 36 0.5× 16 0.3× 12 387

Countries citing papers authored by Anna Germanová

Since Specialization
Citations

This map shows the geographic impact of Anna Germanová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Germanová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Germanová more than expected).

Fields of papers citing papers by Anna Germanová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Germanová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Germanová. The network helps show where Anna Germanová may publish in the future.

Co-authorship network of co-authors of Anna Germanová

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Germanová. A scholar is included among the top collaborators of Anna Germanová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Germanová. Anna Germanová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cibula, David, J Sláma, Lukáš Dostálek, et al.. (2020). Tumour-free distance: a novel prognostic marker in patients with early-stage cervical cancer treated by primary surgery. British Journal of Cancer. 124(6). 1121–1129. 10 indexed citations
2.
Dostálek, Lukáš, J Sláma, Roman Kocián, et al.. (2020). Impact of sentinel lymph node frozen section evaluation to avoid combined treatment in early-stage cervical cancer. International Journal of Gynecological Cancer. 30(6). 744–748. 10 indexed citations
3.
4.
Cibula, David, Nadeem R. Abu‐Rustum, D. Fischerová, et al.. (2018). Surgical treatment of “intermediate risk” lymph node negative cervical cancer patients without adjuvant radiotherapy—A retrospective cohort study and review of the literature. Gynecologic Oncology. 151(3). 438–443. 42 indexed citations
5.
Minig, Lucas, Florian Heitz, David Cibula, et al.. (2017). Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study. Annals of Surgical Oncology. 24(9). 2720–2726. 34 indexed citations
6.
Sláma, J, Ladislav Dušek, D. Fischerová, et al.. (2016). Results of less radical fertility-sparing procedures with omitted parametrectomy for cervical cancer: 5years of experience. Gynecologic Oncology. 142(3). 401–404. 27 indexed citations
7.
Sláma, J, D. Fischerová, Michal Zikán, et al.. (2016). Sensitivity of Follow-Up Methods in Patients After Fertility-Sparing Surgery for Cervical Cancers. International Journal of Gynecological Cancer. 27(1). 147–153. 7 indexed citations
8.
Vlková, Barbora, Marta Kalousová, Anna Germanová, et al.. (2016). Cell-free DNA is higher and more fragmented in intrahepatic cholestasis of pregnancy. Prenatal Diagnosis. 36(12). 1156–1158. 10 indexed citations
9.
Koucký, Michal, Karin Malíčková, Tereza Cindrová‐Davies, et al.. (2014). Low levels of circulating T-regulatory lymphocytes and short cervical length are associated with preterm labor. Journal of Reproductive Immunology. 106. 110–117. 37 indexed citations
10.
Malíčková, Karin, Michal Koucký, Antonı́n Pařı́zek, et al.. (2014). Diagnostic and prognostic value of presepsin in preterm deliveries. The Journal of Maternal-Fetal & Neonatal Medicine. 28(9). 1032–1037. 5 indexed citations
11.
Germanová, Anna, M Jáchymová, Z Hájek, et al.. (2012). Receptor for advanced glycation end products (RAGE) and glyoxalase I gene polymorphisms in pathological pregnancy. Clinical Biochemistry. 45(16-17). 1409–1414. 7 indexed citations
12.
Švabík, Kamil, et al.. (2011). Should hysteroscopy be provided for patients who have undergone instrumental intrauterine intervention after delivery?. Acta Obstetricia Et Gynecologica Scandinavica. 91(4). 514–517. 6 indexed citations
13.
Germanová, Anna, M Jáchymová, Z Hájek, et al.. (2011). Association of pregnancy-associated plasma protein A polymorphism with preeclampsia — A pilot study. Clinical Biochemistry. 44(17-18). 1380–1384. 10 indexed citations
14.
Koucký, Michal, Anna Germanová, Marta Kalousová, et al.. (2010). Low maternal serum matrix metalloproteinase (MMP)-2 concentrations are associated with preterm labor and fetal inflammatory response. Journal of Perinatal Medicine. 38(6). 589–96. 16 indexed citations
15.
Germanová, Anna, Michal Koucký, Z Hájek, et al.. (2009). Soluble receptor for advanced glycation end products in physiological and pathological pregnancy. Clinical Biochemistry. 43(4-5). 442–446. 33 indexed citations
16.
Germanová, Anna, et al.. (2009). Glyoxalase I Glu111Ala Polymorphism in Patients with Breast Cancer. Cancer Investigation. 27(6). 655–660. 15 indexed citations
17.
Kalousová, Marta, Irena Brabcová, Anna Germanová, et al.. (2008). RAGE polymorphisms, renal function and histological finding at 12 months after renal transplantation. Clinical Biochemistry. 42(4-5). 347–352. 8 indexed citations
18.
Hájek, Z, Anna Germanová, Michal Koucký, et al.. (2008). Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study. Journal of Perinatal Medicine. 36(5). 399–404. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rafli van de Laar Breakdown of academic impact, for papers by Juria Akasaka Breakdown of academic impact, for papers by Tatjana E. Vogelvang Breakdown of academic impact, for papers by Liv Cecilie Vestrheim Thomsen Breakdown of academic impact, for papers by Nadiye Köroğlu Breakdown of academic impact, for papers by Nikolaos Burbos Breakdown of academic impact, for papers by Xiuli Yang Breakdown of academic impact, for papers by Thomas Gaillard Breakdown of academic impact, for papers by Ahter Tanay Tayyar Breakdown of academic impact, for papers by Panos Sarhanis
Rankless by CCL
2026